Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Accumulated Expenses (2017 - 2026)

Dyadic International (DYAI) posted Accumulated Expenses of $891420.0 for Q1 2026, down 7.91% sequentially from $967974.0 in Q4 2025, and up 29.03% YoY from $690859.0 in Q1 2025.

Dyadic International (DYAI) Accumulated Expenses (2017 - 2026) Analysis & Trends

Dyadic International has reported Accumulated Expenses for 10 years, with the latest figure at $891420.0 in Q1 2026.

  • Quarterly Accumulated Expenses rose 29.03% year-over-year to $891420.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $891420.0 (up 29.03% YoY) and the FY2025 annual result came in at $967974.0, changed 0.26% from the prior year.
  • Accumulated Expenses slipped to $891420.0 in Q1 2026 per DYAI's latest filing, from $967974.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $533.0 million in Q1 2022 and troughed at $309203.0 in Q2 2022.
  • A 5-year average of $32.1 million and a median of $891420.0 in 2026 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses surged 304110.38% in 2022, then slumped 99.84% in 2023.
  • Over 5 years, Accumulated Expenses stood at $580264.0 in 2022, then dropped by 3.2% to $561720.0 in 2023, then soared by 72.77% to $970462.0 in 2024, then dropped by 0.26% to $967974.0 in 2025, then dropped by 7.91% to $891420.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $891420.0, $967974.0, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Dyadic International 19.98 Mn 19.98 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 891,420.00
Dec 31, 2025 967,974.00
Sep 30, 2025 1.37 Mn
Jun 30, 2025 929,850.00
Mar 31, 2025 690,859.00
Dec 31, 2024 970,462.00
Sep 30, 2024 442,604.00
Jun 30, 2024 870,597.00
Mar 31, 2024 987,973.00
Dec 31, 2023 561,720.00
Sep 30, 2023 429,820.00
Jun 30, 2023 909,482.00
Mar 31, 2023 863,041.00
Dec 31, 2022 580,264.00
Sep 30, 2022 987,891.00
Jun 30, 2022 309,203.00
Mar 31, 2022 533.01 Mn
Dec 31, 2021 405,758.00
Sep 30, 2021 410,780.00
Jun 30, 2021 276,112.00